GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹915 Cr | ₹997 Cr | ₹364 Cr | ₹791 Cr | ₹605 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹915 Cr |
| Mar2024 | ₹997 Cr |
| Mar2023 | ₹364 Cr |
| Mar2022 | ₹791 Cr |
| Mar2021 | ₹605 Cr |
How is Cash Flow from Operating Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹915 Cr | -8.23 | |
| Mar2024 | ₹997 Cr | 173.87 | |
| Mar2023 | ₹364 Cr | -53.97 | |
| Mar2022 | ₹791 Cr | 30.72 | |
| Mar2021 | ₹605 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹29,328.6 Cr | -5.6% | 1.5% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -5.6% |
1.5% |
19.7% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses